Home
/
Imunon, Inc.
/
Financials
/
Quarterly
Imunon, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Imunon, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2022
$125.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$125.0K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$125.0K
May 11, 2023
Q3
2022
Sep 30, 2021
$125.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$125.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$125.0K
May 16, 2022
Q3
2021
Sep 30, 2020
$125.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$125.0K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$125.0K
May 14, 2021
Q3
2020
Sep 30, 2019
$125.0K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$125.0K
Aug 14, 2020
Q1
2020
Mar 31, 2019
$125.0K
May 15, 2020
Q3
2019
Sep 30, 2018
$125.0K
Nov 14, 2019
Q2
2019
Jun 30, 2018
$125.0K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$125.0K
May 15, 2019
Q3
2018
Sep 30, 2017
$375.0K
Nov 14, 2018
Q3
2018
Jun 30, 2017
$125.0K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$125.0K
Aug 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.43M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.74M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($4.10M)
May 12, 2025
Q3
2025
Sep 30, 2024
($4.85M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($4.79M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($4.93M)
May 12, 2025
Q3
2024
Sep 30, 2023
($3.48M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($5.56M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.59M)
May 13, 2024
Q3
2023
Sep 30, 2022
($6.15M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($6.04M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($10.47M)
May 11, 2023
Q3
2022
Sep 30, 2021
($5.41M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.45M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($5.69M)
May 16, 2022
Q3
2021
Sep 30, 2020
($8.07M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($5.34M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.06M)
May 14, 2021
Q3
2020
Sep 30, 2019
($5.48M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($5.90M)
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.48M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($2.77M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($4.15M)
May 12, 2025
Q3
2025
Sep 30, 2024
($4.96M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($5.01M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($5.01M)
May 12, 2025
Q3
2024
Sep 30, 2023
($3.90M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($5.47M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($5.68M)
May 13, 2024
Q3
2023
Sep 30, 2022
($6.17M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($5.98M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($5.84M)
May 11, 2023
Q3
2022
Sep 30, 2021
($5.06M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.07M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($5.38M)
May 16, 2022
Q3
2021
Sep 30, 2020
($4.16M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.77M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($4.77M)
May 14, 2021
Q3
2020
Sep 30, 2019
($5.39M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($5.57M)
Aug 14, 2020